With AstraZeneca’s Crestor Launch In India, The Fight For Statins Market Is Set To Get Fiercer
This article was originally published in PharmAsia News
Executive Summary
MUMBAI -Two months after Merck brought Zocor (simvastatin) into India, its global rival AstraZeneca introduced Crestor (rosuvastatin) at one-fifth of its international prices. Crestor is used in the treatment of dyslipidemia and atherosclerosis